|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Summit Therapeutics (NASDAQ: SMMT) through any online brokerage.
There are no as such competitors for Summit Therapeutics.
The latest price target for Summit Therapeutics (NASDAQ: SMMT) was reported by HC Wainwright & Co. on 2020-11-18. The analyst firm set a price target for 0.00 expecting SMMT to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Summit Therapeutics (NASDAQ: SMMT) is $5.63 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Summit Therapeutics.
There is no upcoming split for Summit Therapeutics.